These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 16368967
1. Binding and internalization of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans, by murine peritoneal macrophages. Chang ZL, Netski D, Thorkildson P, Kozel TR. Infect Immun; 2006 Jan; 74(1):144-51. PubMed ID: 16368967 [Abstract] [Full Text] [Related]
2. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Monari C, Retini C, Casadevall A, Netski D, Bistoni F, Kozel TR, Vecchiarelli A. Eur J Immunol; 2003 Apr; 33(4):1041-51. PubMed ID: 12672070 [Abstract] [Full Text] [Related]
3. Cryptococcus neoformans glucuronoxylomannan induces macrophage apoptosis mediated by nitric oxide in a caspase-independent pathway. Chiapello LS, Baronetti JL, Garro AP, Spesso MF, Masih DT. Int Immunol; 2008 Dec; 20(12):1527-41. PubMed ID: 18927317 [Abstract] [Full Text] [Related]
4. In vivo clearance of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans: a critical role for tissue macrophages. Grinsell M, Weinhold LC, Cutler JE, Han Y, Kozel TR. J Infect Dis; 2001 Aug 15; 184(4):479-87. PubMed ID: 11471106 [Abstract] [Full Text] [Related]
5. The heat shock protein (Hsp) 70 of Cryptococcus neoformans is associated with the fungal cell surface and influences the interaction between yeast and host cells. Silveira CP, Piffer AC, Kmetzsch L, Fonseca FL, Soares DA, Staats CC, Rodrigues ML, Schrank A, Vainstein MH. Fungal Genet Biol; 2013 Nov 15; 60():53-63. PubMed ID: 23954835 [Abstract] [Full Text] [Related]
6. Receptor-mediated clearance of Cryptococcus neoformans capsular polysaccharide in vivo. Yauch LE, Mansour MK, Levitz SM. Infect Immun; 2005 Dec 15; 73(12):8429-32. PubMed ID: 16299344 [Abstract] [Full Text] [Related]
7. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. Yauch LE, Lam JS, Levitz SM. PLoS Pathog; 2006 Nov 15; 2(11):e120. PubMed ID: 17096589 [Abstract] [Full Text] [Related]
8. Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM. J Immunol; 2001 Apr 01; 166(7):4620-6. PubMed ID: 11254720 [Abstract] [Full Text] [Related]
9. Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand. Villena SN, Pinheiro RO, Pinheiro CS, Nunes MP, Takiya CM, DosReis GA, Previato JO, Mendonça-Previato L, Freire-de-Lima CG. Cell Microbiol; 2008 Jun 01; 10(6):1274-85. PubMed ID: 18284419 [Abstract] [Full Text] [Related]
10. A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan. Albuquerque PC, Cordero RJ, Fonseca FL, Peres da Silva R, Ramos CL, Miranda KR, Casadevall A, Puccia R, Nosanchuk JD, Nimrichter L, Guimaraes AJ, Rodrigues ML. Fungal Genet Biol; 2012 Nov 01; 49(11):943-54. PubMed ID: 23010152 [Abstract] [Full Text] [Related]
11. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity. Netski D, Kozel TR. Infect Immun; 2002 Jun 01; 70(6):2812-9. PubMed ID: 12010967 [Abstract] [Full Text] [Related]
12. Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1. De Jesus M, Park CG, Su Y, Goldman DL, Steinman RM, Casadevall A. Med Mycol; 2008 Mar 01; 46(2):153-62. PubMed ID: 18324494 [Abstract] [Full Text] [Related]
14. Cryptococcus neoformans is internalized by receptor-mediated or 'triggered' phagocytosis, dependent on actin recruitment. Guerra CR, Seabra SH, de Souza W, Rozental S. PLoS One; 2014 Mar 01; 9(2):e89250. PubMed ID: 24586631 [Abstract] [Full Text] [Related]
15. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. Fleuridor R, Lees A, Pirofski L. J Immunol; 2001 Jan 15; 166(2):1087-96. PubMed ID: 11145689 [Abstract] [Full Text] [Related]
16. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans. Retini C, Kozel TR, Pietrella D, Monari C, Bistoni F, Vecchiarelli A. Infect Immun; 2001 Oct 15; 69(10):6064-73. PubMed ID: 11553544 [Abstract] [Full Text] [Related]
17. Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct. Albuquerque PC, Fonseca FL, Dutra FF, Bozza MT, Frases S, Casadevall A, Rodrigues ML. Future Microbiol; 2014 Oct 15; 9(2):147-61. PubMed ID: 24571070 [Abstract] [Full Text] [Related]
18. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy. da Silva TA, Hauser PJ, Bandey I, Laskowski T, Wang Q, Najjar AM, Kumaresan PR. Cytotherapy; 2021 Feb 15; 23(2):119-130. PubMed ID: 33303326 [Abstract] [Full Text] [Related]
19. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Cross CE, Collins HL, Bancroft GJ. Immunology; 1997 Jun 15; 91(2):289-96. PubMed ID: 9227330 [Abstract] [Full Text] [Related]
20. Dectin-3 Recognizes Glucuronoxylomannan of Cryptococcus neoformans Serotype AD and Cryptococcus gattii Serotype B to Initiate Host Defense Against Cryptococcosis. Huang HR, Li F, Han H, Xu X, Li N, Wang S, Xu JF, Jia XM. Front Immunol; 2018 Jun 15; 9():1781. PubMed ID: 30131805 [Abstract] [Full Text] [Related] Page: [Next] [New Search]